* Shares in India's Jubilant Life Sciences plunge 14.2
percent to a two-week low.
* The company reported a net loss of 941 million rupees in the
September quarter, compared with a net loss of 805.8 million
rupees posted a year ago.
* Macquarie Securities cut its EPS estimates for the company to
23.6 rupees and 30.3 rupees for FY15 and FY16 from 26 rupees and
* "We believe free cash flow generation and margin recovery are
quintessential for investors to regain confidence," it added.